In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.

AM2-S31N 通道阻滞剂的体外药代动力学优化发现了对耐药性甲型流感病毒具有强效抗病毒活性的慢结合抑制剂